🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of Tylenol, claiming the firms withheld safety concerns that the medication created to pediatric brain development.

The court filing follows four weeks after Former President Trump publicized an unsubstantiated connection between taking acetaminophen - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against J&J, which previously sold the drug, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of pain and promoting medication without regard for the potential hazards."

The company says there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking countless individuals to line their pockets," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a verified association between taking paracetamol and autism spectrum disorder."

Groups speaking for medical professionals and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to treat pain and elevated temperature, which can pose serious health risks if ignored.

"In over twenty years of research on the use of acetaminophen in pregnancy, no reliable research has conclusively proven that the usage of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in young ones," the group stated.

The lawsuit cites latest statements from the Trump administration in asserting the medication is potentially dangerous.

In recent weeks, the former president raised alarms from public health officials when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

Federal regulators then published an announcement that medical professionals should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in young ones has remains unverified.

The Health Department head Kennedy, who manages the FDA, had promised in spring to conduct "extensive scientific investigation" that would establish the source of autism in a limited time.

But experts cautioned that discovering a sole reason of autism spectrum disorder - considered by experts to be the result of a complex mix of genetic and external influences - would not be simple.

Autism is a form of permanent neurological difference and disability that impacts how individuals encounter and engage with the surroundings, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - who supports Trump who is seeking US Senate - asserts Kenvue and J&J "deliberately disregarded and attempted to silence the science" around paracetamol and autism.

The lawsuit seeks to make the firms "remove any promotional materials" that asserts acetaminophen is secure for women during pregnancy.

This legal action parallels the grievances of a assembly of guardians of minors with autism spectrum disorder and ADHD who took legal action against the makers of acetaminophen in two years ago.

The court dismissed the case, saying research from the parents' expert witnesses was inconclusive.